Heparin Market

Report Highlights

The scope of this report is broad and covers different types of heparin, along with the applications for heparin. The market is broken down by types of heparins, applications and regional markets. Revenue forecasts from 2019 to 2025 are given for each major type of Heparin, application, route of administration and regional market, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Heparin markets; it explains the major market drivers of the global heparin industry, current trends within the industry, major applications and the regional dynamics of the global heparin market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global heparin industry.

Report Includes

• 62 tables
• An up-to-date analysis of the global heparin market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for global heparin market, and corresponding market share analysis by type, application, route of administration and region for each market segment.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Heparin, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of new products and products still in the development and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Heparin market as compared to overall global economy.
• Insight into the growth development strategies of major heparin manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including GlaxoSmithKline plc, Pfizer, Inc., Leo Pharma A/S, Baxter, Dr. Reddy’s Laboratories Ltd.

Summary.

Heparin, also called as unfractionated heparin (UFH), is a glycosaminoglycan which occurs naturally. It is used as blood thinner in medicine. It is specifically useful for the treatment of heart attacks and unstable angina. It is administered into a vein or injected under the skin. It is used to treat a number of health problems, such as acute coronary syndrome and atrial fibrillation, as well as cardiopulmonary bypass and hemofiltration while cardiac surgery.

On the basis of types of heparins, the market is divided into Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin and Unfractionated Heparin. In 2020, the Low Molecular Weight Heparin segment has held the significant share in the market.